REVOLUTION MEDICINES INC

NASDAQ: RVMD (Revolution Medicines, Inc.)

Last update: 10 Sep, 4:20AM

42.12

0.28 (0.67%)

Market Trend

Short Term Medium Term
Industry Biotechnology (US) Mixed Bearish
Biotechnology (Global) Mixed Bearish
Stock Revolution Medicines, Inc. Bullish Bullish

Stockmoo Score

0.3

Similar Stocks

Stock Market Cap DY P/E P/B
RVMD 7 B - - 4.47
IONS 7 B - - 22.54
LGND 2 B - 43.88 2.45
LQDA 826 M - - 12.18
CDMO 720 M - - 12.28
OPT 501 M - - 4.31

Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.

Sector Healthcare
Industry Biotechnology
Investment Style Small Core
52 Weeks Range
15.44 (-63%) — 48.61 (15%)
Price Target Range
54.00 (28%) — 63.00 (49%)
High 63.00 (Jefferies, 49.57%) Buy
Median 55.50 (31.77%)
Low 54.00 (JP Morgan, 28.21%) Buy
54.00 (Barclays, 28.21%) Buy
Average 57.13 (35.64%)
Total 8 Buy
Avg. Price @ Call 43.51
Firm Date Target Price Call Price @ Call
HC Wainwright & Co. 12 Aug 2024 56.00 (32.95%) Buy 42.98
16 Jul 2024 56.00 (32.95%) Buy 46.77
JP Morgan 08 Aug 2024 54.00 (28.21%) Buy 41.98
Needham 08 Aug 2024 61.00 (44.82%) Buy 41.98
16 Jul 2024 62.00 (47.20%) Buy 46.77
Wedbush 08 Aug 2024 59.00 (40.08%) Buy 41.98
Barclays 18 Jul 2024 54.00 (28.21%) Buy 46.04
12 Jul 2024 52.00 (23.46%) Buy 45.14
B of A Securities 16 Jul 2024 55.00 (30.58%) Buy 46.77
Oppenheimer 16 Jul 2024 55.00 (30.58%) Buy 46.77
Jefferies 08 Jul 2024 63.00 (49.57%) Buy 39.58
Show more

No data within this time range.

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2024 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria